Kreuz M, Cardoso J, Sobreira L, Cavalcanti Souza M, Campos L, Kelly F
Clin Transl Oncol. 2025; .
PMID: 39825996
DOI: 10.1007/s12094-024-03839-0.
Stenman C, Wallinder A, Holmberg E, Karason K, Magnusson J, Dellgren G
Transpl Int. 2024; 37:12127.
PMID: 39314925
PMC: 11417467.
DOI: 10.3389/ti.2024.12127.
Stenman C, Wallinder A, Holmberg E, Karason K, Magnusson J, Dellgren G
Transpl Int. 2024; 37:12109.
PMID: 39314924
PMC: 11417470.
DOI: 10.3389/ti.2024.12109.
El-Amir Z, Jamil A, Solanki D, Mansuri U, Mathew M, Singh J
Proc (Bayl Univ Med Cent). 2024; 37(5):804-812.
PMID: 39165820
PMC: 11332645.
DOI: 10.1080/08998280.2024.2375688.
Dharnidharka V, Ruzinova M, Marks L
Semin Nephrol. 2024; 44(1):151503.
PMID: 38519279
PMC: 11213680.
DOI: 10.1016/j.semnephrol.2024.151503.
Global research productivity of post-transplant lymphoproliferative disorder: a bibliometric study.
Rawashdeh B, AlRyalat S, Rawshdeh A, Abuassi M, Al-Mansour Z, El-Hinnawi A
Ann Med Surg (Lond). 2024; 86(3):1522-1530.
PMID: 38463089
PMC: 10923329.
DOI: 10.1097/MS9.0000000000001771.
Prevention of Oncogenic (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients.
Atamna A, Yahav D, Hirzel C
Transpl Int. 2023; 36:11856.
PMID: 38046068
PMC: 10689273.
DOI: 10.3389/ti.2023.11856.
Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022.
Ishikura K, Omae K, Sasaki S, Shibagaki Y, Ichioka S, Okuda Y
Int J Clin Oncol. 2023; 28(10):1333-1342.
PMID: 37418141
DOI: 10.1007/s10147-023-02375-1.
Post-transplant Lymphoproliferative Disorder (PTLD) in the US Population: Demographics, Treatment Characteristics, and Survival Analysis.
Ullah A, Lee K, Malham K, Yasinzai A, Khan I, Asif B
Cureus. 2023; 15(5):e39777.
PMID: 37398803
PMC: 10312545.
DOI: 10.7759/cureus.39777.
NONMELANOMA SKIN CANCER IN A HEART TRANSPLANT PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE.
Rudez L, Sklebar T, Ceovic R
Acta Clin Croat. 2022; 61(1):157-165.
PMID: 36398077
PMC: 9616031.
DOI: 10.20471/acc.2022.61.01.21.
Probable posttransplant lymphoproliferative disorder after pediatric living donor liver transplantation: Is a biopsy still needed?.
Matsumura M, Miyagi S, Tokodai K, Kashiwadate T, Fujio A, Miyazawa K
Clin Case Rep. 2022; 10(11):e6454.
PMID: 36348984
PMC: 9634264.
DOI: 10.1002/ccr3.6454.
Treatment Advances in EBV Related Lymphoproliferative Diseases.
Lv K, Yin T, Yu M, Chen Z, Zhou Y, Li F
Front Oncol. 2022; 12:838817.
PMID: 35515118
PMC: 9063483.
DOI: 10.3389/fonc.2022.838817.
Comparison of Post-Transplantation Lymphoproliferative Disorder Risk and Prognostic Factors between Kidney and Liver Transplant Recipients.
Mucha K, Staros R, Foroncewicz B, Ziarkiewicz-Wroblewska B, Kosieradzki M, Nazarewski S
Cancers (Basel). 2022; 14(8).
PMID: 35454860
PMC: 9024969.
DOI: 10.3390/cancers14081953.
Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation.
Asleh R, Alnsasra H, Habermann T, Briasoulis A, Kushwaha S
Front Cardiovasc Med. 2022; 9:787975.
PMID: 35282339
PMC: 8904724.
DOI: 10.3389/fcvm.2022.787975.
Post Transplant Lymphoproliferative Disorder.
Gupta D, Mendonca S, Chakraborty S, Chatterjee T
Indian J Hematol Blood Transfus. 2020; 36(2):229-237.
PMID: 32425371
PMC: 7229077.
DOI: 10.1007/s12288-019-01182-x.
Post-transplant malignancies in alcoholic liver disease.
Singh A, De A, Singh V
Transl Gastroenterol Hepatol. 2020; 5:30.
PMID: 32258534
PMC: 7063507.
DOI: 10.21037/tgh.2019.11.18.
Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches.
Abbas F, Kossi M, Shaheen I, Sharma A, Halawa A
World J Transplant. 2020; 10(2):29-46.
PMID: 32226769
PMC: 7093305.
DOI: 10.5500/wjt.v10.i2.29.
Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes.
Fujimoto A, Suzuki R
Cancers (Basel). 2020; 12(2).
PMID: 32024048
PMC: 7072403.
DOI: 10.3390/cancers12020328.
Colorectal Cancer Characteristics and Outcomes after Solid Organ Transplantation.
Merchea A, Shahjehan F, Croome K, Cochuyt J, Li Z, Colibaseanu D
J Oncol. 2019; 2019:5796108.
PMID: 30941176
PMC: 6421000.
DOI: 10.1155/2019/5796108.
Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.
Smatti M, Al-Sadeq D, Ali N, Pintus G, Abou-Saleh H, Nasrallah G
Front Oncol. 2018; 8:211.
PMID: 29951372
PMC: 6008310.
DOI: 10.3389/fonc.2018.00211.
